We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guide gives an overview of the innovation pathway for products to be used by the NHS.
Sets out recommendations to speed up access to innovative healthcare and technologies, to improve efficiency and outcomes for NHS patients.
Proposals for accelerated access pathways for medicines, diagnostics, medical devices and digital products.
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
A new Accelerated Access Review website is asking for views on how to improve access to transformative medicines and medical technology.
Hilary Newiss, Chair of National Voices, asks patients for their ideas on how to improve the NHS.
Sir Hugh Taylor sets out 5 propositions to speed up access to transformative health technology that can change the lives of NHS patients.
Barriers to innovation in medicines and medicinal technology and the opportunities for improvement: a study by Deloitte and partners.
Richard Barker, Director of CASMI, sets out his vision for a development and approval pathway for high impact innovations.
Lord Prior welcomes new ambitions to speed up patient access to innovative new treatments.
The Review has established various routes for people to give their views on quicker access to transformative medicines and medical technology.
Looks at issues relating to the ethics of medicines adaptive pathways for patients (MAPPs) including the use of real world data.
New recommendations set out how patients could get quicker access to innovative new diagnostic tools, treatments, and medical technologies.
Hilary Newiss, Chair of National Voices, asks for your opinion on how to give patients and service users a say at every stage of innovation.
Dr Stuart Dollow, founder of Vermilion Life Sciences and Accelerated Access champion sets out his vision.
Asking the right questions early on is important if innovations are to be adopted across the NHS, argues John Jeans.
International insights into emerging and effective practice in improving access to medicines and medical technology: study by Rand Europe.
Richard Murray, AAR’s champion for affordable national funding models, puts the case for reforming national systems and processes.
Sir Hugh Taylor invites you to contribute your views to the Accelerated Access Review.
Sir Hugh Taylor announces, and explains the benefits of, an extension of the review.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.